favicon

T4K3.news

Ketamine Queen pleads guilty

A California woman known as the Ketamine Queen will plead guilty to federal drug charges connected to Matthew Perry's overdose.

August 18, 2025 at 08:07 PM
blur 'Ketamine Queen' to plead guilty in Matthew Perry's death, officials say

California woman known as the Ketamine Queen will plead guilty to federal drug charges linked to Matthew Perry's overdose.

Ketamine Queen pleads guilty in Perry death case

Jasveen Sangha, 42, known as the Ketamine Queen, has agreed to plead guilty to one count of maintaining a drug involved premises, three counts of distribution of ketamine, and one count of distribution of ketamine resulting in death or serious bodily injury, according to the U.S. Attorney's Office for the Central District of California. The plea carries a maximum sentence of 65 years in prison, with sentencing set to occur in the coming weeks, the office said. The development follows guilty pleas from other defendants, including Perry's live-in personal assistant and two doctors, who admitted to ketamine distribution in connection with the actor's death. Perry, 54, was found dead in his Pacific Palisades home in October 2023, with the Los Angeles County Medical Examiner ruling the death an accidental ketamine overdose. Prosecutors say Sangha worked with an associate to supply the drug and that 51 vials were sold in the weeks before the death. The plea release notes that Sangha admitted selling four vials to Cory McLaury in 2019, and that the assistant, Kenneth Iwamasa, injected Perry on three occasions. A text message cited in the release shows a co-defendant saying, I’m 90% sure everyone is protected, while describing the assistant as the enabler.

Key Takeaways

✔️
Sangha will plead guilty to multiple ketamine charges
✔️
Possible maximum sentence reaches 65 years
✔️
Perry case links to several co defendants who pled guilty
✔️
55 vials were sold before the overdose, including four to Cory McLaury
✔️
The assistant administered injections that led to death
✔️
The case spotlights gaps between medical use of ketamine and illegal sales
✔️
Public discussion may push tighter oversight of ketamine distribution

""She's taking responsibility for her actions.""

Comment from Sangha's attorney after the plea was announced

""I'm 90% sure everyone is protected""

Fleming's text message cited in the plea release

""So the Assistant was the enabler.""

Text message cited in the plea release

""I never dealt with [Perry]. Only his Assistant.""

Text message cited in the plea release

The case underscores how illegal drug networks can weave through private circles even when a high profile figure is involved. It raises questions about the line between legitimate medical use of ketamine for depression and unsupervised, distribution-driven doses that can fuel addiction and tragedy. As prosecutors pursue multiple defendants, the story highlights broader concerns about oversight, patient safety, and the extent to which accountability reaches beyond the immediate suppliers. The Perry case may prompt renewed scrutiny of ketamine access, monitoring, and the social dynamics that enable private sale networks tied to celebrity cases.

Highlights

  • Responsibility travels fastest through the truth
  • Text messages become courtroom memory
  • The enabler line cuts deep
  • Accountability travels in the smallest details

High risk due to sensitive legal case and public health concerns

The Perry death case involves multiple defendants and drug distribution linked to a celebrity, raising public scrutiny and policy questions about drug treatment and regulation. The case highlights the tension between medical ketamine use and illegal supply chains.

Observers will watch how the plea shapes accountability and policy changes.

Enjoyed this? Let your friends know!

Related News